The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Thursday, August 06, 2020
Ferring is recalling all lots on the market of DDAVP Nasal Spray, Desmopressin Acetate Nasal Spray, and STIMATE Nasal Spray to the consumer level.
read more
Janssen Research & Development
Janssen announced the FDA has approved the sNDA for SPRAVATO CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in ...
read more
Janssen Research & Development
Janssen announced the FDA has approved an expanded indication for STELARA as a treatment for pediatric patients with the skin lesions or plaques ...
read more
Pacira announced the FDA has accepted the its sNDA seeking expansion of the EXPAREL label to include single-dose infiltration to provide postsurgical ...
read more
NeuroRx has been granted IND permission to test RLF-100 for inhaled use in patients with moderate and severe COVID-19 in order to prevent progression ...
read more
Wednesday, August 12, 2020
PTC announced the FDA has approved Evrysdi for spinal muscular atrophy in adults and children 2 months and older.
read more
Thursday, August 13, 2020
Amydis has received a new grant from MJFF for the Company’s pioneering retinal tracer program for alpha-synuclein.
read more
Moderna announced that the U.S. government has secured 100 million doses of mRNA-1273.
read more
Wednesday, August 19, 2020
Neuroptika announced completion of enrollment in a Phase 2 clinical controlled, double-masked trial of NRO-1 for the treatment of patients with dry ...
read more
Thursday, August 20, 2020
United Therapeutics announced the FDA accepted for review the sNDA for Tyvaso Inhalation Solution for the treatment of pulmonary hypertension ...
read more
Thursday, August 20, 2020
AstraZeneca Pharmaceuticals
AstraZeneca's Imfinzi has received acceptance for its sBLA and has also been granted Priority Review in the US for a new four-week, fixed-dose regimen...
read more
SCA is voluntarily recalling 10 lots of Heparin Sodium to the hospital/user level.
read more
A preclinical study testing the generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infection.
read more
Wednesday, August 26, 2020
Clearside Biomedical announced the recent issuance of three additional patents in the United States and Europe.
read more
Hackensack Meridian Health is now enrolling individuals in a COVID-19 vaccine clinical trial.
read more